Stock CYCLACEL PHARMACEUTICALS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Cyclacel Pharmaceuticals Inc Nasdaq

Equities

US23254L3069

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Cyclacel Pharmaceuticals Inc
04-30 Top Midday Gainers MT
04-30 Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday Ahead of FOMC Meeting MT

Chart calendar Cyclacel Pharmaceuticals Inc

00efaf809aaa.y03Uw5CXNSm9Dbq8BW7YeFiv6HetaBg-2Zm1gwdPuKk.swWti9-vcxD4YODeUgP1KCzDiTyZEnBwrtXT1X4jzMipGOKx2dUBYOJjyQ~e7fe04f9ea9e46c9df02a8c05ccd7adf

Upcoming events on Cyclacel Pharmaceuticals Inc

07/05/2024 Q1 2024 Earnings Release (Projected)
31/05/2024 23:30 American Society of Clinical Oncology Annual Meeting - Abstract No: 3125
06/08/2024 Q2 2024 Earnings Release (Projected)
12/11/2024 Q3 2024 Earnings Release (Projected)
31/03/2025 Q4 2024 Earnings Release (Projected)

Past events on Cyclacel Pharmaceuticals Inc

09/04/2024 21:30 American Association for Cancer Research Meeting - Abstract No: 5711 / 11
08/04/2024 17:00 American Association for Cancer Research Meeting - Abstract No: 2117 / 8
07/04/2024 21:30 American Association for Cancer Research Meeting - Abstract No: 518 / 15
19/03/2024 20:30 Q4 2023 Earnings Call
19/03/2024 20:05 Q4 2023 Earnings Release
16/03/2024 Roth Conference
26/02/2024 19:30 BIO CEO & Investor Conference
08/01/2024 19:00 Biotech Showcase
17/12/2023 Reverse Split: 1 of 15
08/12/2023 14:30 Extraordinary Shareholders Meeting
13/11/2023 21:30 Q3 2023 Earnings Call
13/11/2023 21:05 Q3 2023 Earnings Release
09/08/2023 21:30 Q2 2023 Earnings Call
09/08/2023 21:05 Q2 2023 Earnings Release
13/06/2023 17:00 Annual General Meeting
11/05/2023 21:30 Q1 2023 Earnings Call
11/05/2023 21:05 Q1 2023 Earnings Release
13/03/2023 22:00 Roth Conference
13/03/2023 14:00 Oppenheimer Healthcare Conference
06/03/2023 21:30 Q4 2022 Earnings Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,42
0,39
7.97%
0,00

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-9,68
-9,42
-2.75%		-10,6
-10,2
-4.7%		-22,9
-23,1
0.75%		-27,7
-25,7
-7.71%		-25,5
-26,3
3.24%
-16,3

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-9,13
-8,88
-2.82%		-9,68
-9,25
-4.68%		-22,7
-23,0
1.22%		-25,9
-24,4
-6.29%		-25,6
-26,1
2.17%
-26,5

Net income
Million USD		Released
Forecast
Spread 		-8,03
-7,99
-0.49%		-12,4
-8,41
-47.43%		-19,1
-20,4
6.36%		-21,4
-21,3
-0.4%		-22,8
-23,2
1.72%
-23,7

EPS
USD		Released
Forecast
Spread 		-150
-153
1.96%		-51,3
-38,4
-33.42%		-32,1
-34,6
7.16%		-28,5
-26,7
-6.74%		-26,8
-20,2
-32.25%
-13,4

Announcement Date26/02/2025/02/2128/03/2206/03/2319/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,37
0,00
- 		0,02
0,00
- 		0,03
0,00
-
0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-6,53
-6,71
2.62%		-6,56
-7,15
8.3%		-5,79
-6,98
17.08%		-6,47
-6,79
4.8%		-8,85
-6,94
-27.53%		-7,32
-9,28
21.1%		-5,93
-7,12
16.78%		-6,85
-5,99
-14.3%		-5,36
-6,21
13.73%
-4,54


-4,08


-3,88


-3,76

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-6,49
-6,72
3.37%		-5,25
-7,27
27.88%		-5,56
-7,07
21.4%		-6,11
-6,83
10.5%		-9,00
-6,78
-32.68%		-7,12
-9,29
23.3%		-6,03
-7,26
16.94%		-6,70
-5,82
-15.16%		-5,69
-6,21
8.31%
-6,49


-6,61


-6,72


-6,84

Net income
Million USD		Released
Forecast
Spread 		-5,34
-6,65
19.68%		-4,16
-7,07
41.17%		-4,63
-5,66
18.24%		-5,15
-6,37
19.27%		-7,47
-6,54
-14.15%		-5,85
-8,42
30.43%		-5,50
-6,59
16.63%		-6,15
-5,26
-16.97%		-5,32
-5,70
6.61%
-5,99


-6,11


-6,22


-6,34

EPS
USD		Released
Forecast
Spread 		-8,10
-10,3
21.17%		-6,30
-10,3
38.69%		-6,90
-8,06
14.42%		-6,30
-7,65
17.65%		-9,00
-7,24
-24.35%		-7,05
-9,95
29.15%		-6,60
-7,55
12.58%		-7,35
-5,45
-34.86%		-6,23
-5,89
-5.71%
-4,56


-3,44


-3,20


-2,59

Announcement Date28/03/2211/05/2210/08/2209/11/2206/03/2311/05/2309/08/2313/11/2319/03/24----

Upcoming sector events for Cyclacel Pharmaceuticals Inc

Today 11:00 AURINIA PHARMACEUTICALS INC.: Q1 2024 Earnings Release
Today 11:30 SPRINGWORKS THERAPEUTICS, INC.: Q1 2024 Earnings Release
Today 11:30 REGENERON PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
Today 12:00 AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
Today 16:00 GENMAB A/S: Q1 2024 Earnings Release
Today 21:01 ASCENDIS PHARMA A/S: Q1 2024 Earnings Release
05/05/2024 FRAZIER LIFESCIENCES ACQUISITION CORPORATION: Q1 2024 Earnings Release (Projected)
05/05/2024 KRYSTAL BIOTECH, INC.: Q1 2024 Earnings Release
05/05/2024 MERUS N.V.: Q1 2024 Earnings Release (Projected)
05/05/2024 VAXCYTE, INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Cyclacel Pharmaceuticals Inc

Today ZENTALIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)
Today DENALI THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected)
Today GERON CORPORATION: Q1 2024 Earnings Release
Today KURA ONCOLOGY, INC.: Q1 2024 Earnings Release
Today KEROS THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
Today ALECTOR, INC.: Q1 2024 Earnings Release (Projected)
Today ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release
Today TRAVERE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
Today ARDELYX, INC.: Q1 2024 Earnings Release
Today ZYMEWORKS INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. CYCC Stock
  4. Stock
  5. Calendar Cyclacel Pharmaceuticals Inc